These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9812180)
21. High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients. Sörgel F; Stephan U; Wiesemann HG; Gottschalk B; Stehr C; Rey M; Böwing HB; Dominick HC; Geldmacher von Mallinckrodt M Infection; 1987; 15(5):385-96. PubMed ID: 3319914 [TBL] [Abstract][Full Text] [Related]
22. Overview of the pharmacokinetics of fleroxacin. Nightingale CH Am J Med; 1993 Mar; 94(3A):38S-43S. PubMed ID: 8452184 [TBL] [Abstract][Full Text] [Related]
23. Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data. De Sutter PJ; Van Haeverbeke M; Van Braeckel E; Van Biervliet S; Van Bocxlaer J; Vermeulen A; Gasthuys E CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):951-966. PubMed ID: 35748042 [TBL] [Abstract][Full Text] [Related]
24. Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis. Bulitta JB; Jiao Y; Drescher SK; Oliver A; Louie A; Moya B; Tao X; Wittau M; Tsuji BT; Zavascki AP; Shin BS; Drusano GL; Sörgel F; Landersdorfer CB Clin Pharmacokinet; 2019 Feb; 58(2):143-156. PubMed ID: 29936678 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019. De Sutter PJ; Gasthuys E; Van Braeckel E; Schelstraete P; Van Biervliet S; Van Bocxlaer J; Vermeulen A Clin Pharmacokinet; 2020 Dec; 59(12):1551-1573. PubMed ID: 32808233 [TBL] [Abstract][Full Text] [Related]
26. Oral theophylline disposition in cystic fibrosis. Georgitis JW; Eigen H; Warner R; Gonzales MA Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics. Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937 [TBL] [Abstract][Full Text] [Related]
28. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients. Taburet AM; Devillers A; Thomare P; Fillastre JP; Veyssier P; Singlas E Clin Pharmacokinet; 1990 Jul; 19(1):80-8. PubMed ID: 2116257 [TBL] [Abstract][Full Text] [Related]
29. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis. Singlas E; Leroy A; Sultan E; Godin M; Moulin B; Taburet AM; Dhib M; Fillastre JP Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions. Knoop C; Vervier I; Thiry P; De Backer M; Kovarik JM; Rousseau A; Marquet P; Estenne M Transplantation; 2003 Aug; 76(4):683-8. PubMed ID: 12973109 [TBL] [Abstract][Full Text] [Related]
31. Altered pharmacokinetics of omeprazole in cystic fibrosis knockout mice relative to wild-type mice. Tallman MN; Ali SY; Smith PC Drug Metab Dispos; 2004 Sep; 32(9):902-5. PubMed ID: 15319328 [TBL] [Abstract][Full Text] [Related]
32. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
33. Rapid methylprednisolone clearance in a patient with cystic fibrosis. Green CG; Kraus CK; Lemanske RF; Farrell PM; Jusko WJ Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253 [TBL] [Abstract][Full Text] [Related]
34. Antibiotic therapy and fat digestion and absorption in cystic fibrosis. Lisowska A; Pogorzelski A; Oracz G; Skorupa W; Cofta S; Szydłowski J; Socha J; Walkowiak J Acta Biochim Pol; 2011; 58(3):345-7. PubMed ID: 21738905 [TBL] [Abstract][Full Text] [Related]
35. Dysfunction of the non-neuronal cholinergic system in the airways and blood cells of patients with cystic fibrosis. Wessler I; Bittinger F; Kamin W; Zepp F; Meyer E; Schad A; Kirkpatrick CJ Life Sci; 2007 May; 80(24-25):2253-8. PubMed ID: 17346753 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. De Paepe P; Belpaire FM; Buylaert WA Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864 [TBL] [Abstract][Full Text] [Related]
37. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [TBL] [Abstract][Full Text] [Related]
38. Hepatic drug clearance in patients with mild cystic fibrosis. Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824 [TBL] [Abstract][Full Text] [Related]
39. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. Johnson LG; Boyles SE; Wilson J; Boucher RC J Clin Invest; 1995 Mar; 95(3):1377-82. PubMed ID: 7533790 [TBL] [Abstract][Full Text] [Related]
40. Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency. Mascarenhas MR; Mondick J; Barrett JS; Wilson M; Stallings VA; Schall JI J Clin Pharmacol; 2015 Aug; 55(8):854-65. PubMed ID: 25689042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]